Convergence of Engineering and Biology
The McDevitt lab is focused on the engineering of innovative technologies to translate the morphogenic potential of stem cells as models of development and disease, as well to develop cellular and molecular therapies aimed to treat degenerative diseases and traumatic injuries.
Since stem cells are promising for a number of applications, the emphasis of the McDevitt Lab is on the development of biologic technology platforms to advance therapies that span multiple diseases.
Our technologies are applicable to a wide variety of diseases, including cardiovascular and neurological disorders. Specific diseases that we can apply our research to include treatments for diabetes, chronic wounds, aging, arthritis, and other autoimmune disorders. The McDevitt lab's work also has other applications, including wound healing, irritable bowel syndrome, epilepsy and bone regeneration to name just a few.